The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. This year’s metric has recorded a Price increase of 9.20%. However, over the past six months, we’ve seen a stronger performance of -39.42%. The price of PHIO leaped by -1.20% over the last 30 days. And in the last five days, it has surged by 24.68%.
The stock market performance of Phio Pharmaceuticals Corp has been fairly unsteady. Over the last year, the company’s stock hit its highest at $6.85 on 05/18/23, while the lowest price during the same time frame was $0.50, recorded on 01/26/24.
52-week price history of PHIO Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Phio Pharmaceuticals Corp’s current trading price is -87.88% away from its 52-week high, while its distance from the 52-week low is 65.98%. The stock’s price range for this period has been between $0.50 and $6.85. The Healthcare sector company’s shares saw a trading volume of about 7.25 million for the day, which was higher than the average daily volume of 0.32 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Phio Pharmaceuticals Corp (PHIO) has experienced a quarterly rise of 23.88% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 3.81M and boasts a workforce of 9 employees.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7828, with a change in price of -0.1191. Similarly, Phio Pharmaceuticals Corp recorded 626,302 in trading volume during the last 100 days, posting a change of -12.55%.
PHIO’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for PHIO stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
PHIO Stock Stochastic Average
As of today, the raw stochastic average of Phio Pharmaceuticals Corp over the past 50 days is 47.01%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 50.56%. Additionally, the Stochastic %K and %D values for the company were 25.18% and 13.72%, respectively, over the past 20 days.
